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Besides the contribution in cell death, apoptosis-inducing factor (AIF) also exerts roles in other cel-
lular activities, which are largely unknown. The CCAAT-enhancer binding protein alpha (C/EBPa) is
required for differentiation of adipocytes and granulocytes. Here we report that, during 3T3-L1 adi-
pocyte differentiation, AIF expression is robustly upregulated via transcriptional regulation by C/
EBPa. The upregulated effect is also conﬁrmed by knockdown and ectopic expression of C/EBPa
in U937 and MCF-7 cells respectively with and without endogenous expression of C/EBPa protein.
We also reveal that AIF knockdown attenuates 3T3-L1 adipocyte differentiation, presumably due
to the mitochondrial respiratory chain deﬁciency. These results provide evidence for the role of
AIF in adipocyte differentiation.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Apoptosis-inducing factor (AIF), a mitochondrial ﬂavoprotein, is
well known as a caspases-independent cell death inducing factor
[1]. During apoptotic signaling, AIF is released from the mitochon-
dria with permeabilization of the mitochondrial membrane, and
translocates to the nucleus where it induces chromatin condensa-
tion and large-scale DNA cleavage [2].
It is supposed that AIF also plays an important role in mitochon-
drial function. Under physiological conditions, AIF is conﬁned to
the inter-membrane space of mitochondria and possesses an
NADH oxidase activity [3]. Notably, cells lacking AIF exhibit severe
reduction of respiratory chain complex I activity [4]. Inactivating
AIF in the early mouse embryo causes abnormal cell death presum-
ably because of reduced mitochondrial complex I activity [5]. Tar-
geted deletion of AIF protects mouse from obesity and diabetes,
due to decreased mitochondrial oxidative phosphorylation [6].
Very recently, a disease-segregating mutation of AIFM1 gene,
encoding AIF that deletes arginine 201 was reported in two malechemical Societies. Published by E
-Qing South Road, Shanghai
en), jywangls@shsmu.edu.cninfant patients who were given a diagnosis of progressive mito-
chondrial encephalomyopathy [7].
These evidences from cell lines, rodent model and clinical re-
ports indicate that besides apoptosis induction, AIF may also play
important roles in other cellular activities, which are largely un-
known to date. Here we report that AIF gene is a transcriptional
target of CCAAT/enhancer binding protein a (C/EBPa), which is re-
quired for differentiation of adipocytes [8] and neutrophil granulo-
cytes [9], and controls cellular proliferation in vivo [10]. We also
show that AIF expression is positively controlled by C/EBPa in leu-
kemic U937 cells, mouse liver, as well as during the process of 3T3-
L1 adipocyte differentiation. In turn, AIF participates in adipocyte
differentiation, probably throughmaintaining the function of mito-
chondrial respiratory chain complex I.
2. Materials and methods
2.1. Cell culture and adipocyte differentiation
293T, MCF-7 and 3T3-L1 cells were cultured in high-glucose
DMEM (Invitrogen, Carlsbad, CA) containing 10% FBS (Gibco BRL,
Gaithersburg, MD). Leukemic cell lines U937, U937-NC, U937-siC/
EBPa (generated as previously reported [11]) were cultured in
RPMI-1640 medium (Sigma–Aldrich, St. Louis, MI) supplemented
with 10% FBS. 3T3-L1 differentiation was induced according to a
previous procedure [8].lsevier B.V. All rights reserved.
Fig. 1. AIF expression increases coincidentally with C/EBPa during 3T3-L1 adipocyte differentiation. 3T3-L1 adipocyte differentiation was induced by treatment with a
hormone mixture. (A) Total protein at indicated time points were subjected to Western blot with indicated antibodies. Coomassie blue staining was used as loading control.
(B) Total RNA at indicated time points were subjected to quantitative realtime PCR with b-actin as an internal control. Error bars represent S.D. (n = 3; ⁄⁄,##P < 0.005 compared
to the control; Student’s t-test). (C and D) 3T3-L1-NC or 3T3-L1-siC/EBPa cells were induced to differentiate. Cells were collected at indicated time points to detect protein (C)
and mRNA (D) levels with indicated antibodies and primers (n = 3; ⁄P < 0.05, ⁄⁄P < 0.005; Student’s t-test).
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To visualize lipid accumulation, cells were stained with Oil-Red-
O (Sigma) [8]. For quantiﬁcation of triglycerides production, 1 ml of
isopropyl alcohol was added to the stained culture dish. Absor-
bance of the extracted dye was monitored spectrophotometrically
at 510 nm.
2.3. Animals
Liver-speciﬁc C/EBPa-null mice were generated by crossing C/
EBPa-ﬂoxed mice (purchased from The Jackson Laboratory) with
mice carrying the albumin-Cre (AlbCre) transgene (purchased from
Model Animal Research Center of Nanjing University). Experiments
were performed using liver and kidney cells from C/EBPaﬂox/
ﬂox  AlbCre+ (KO) and C/EBPaﬂox/ﬂox  AlbCre (FLOX) mice. All
procedures were approved by the local ethics committee of Shang-
hai Jiao-Tong University School of Medicine.
2.4. Plasmids and constructs
cDNAs of C/EBPa, PU.1, RUNX1, C/EBPb (kindly provided by Pro-
fessor Qi-Qun Tang) and CHOP were cloned and inserted into
pcDNA3 (Invitrogen). For siRNA in 3T3-L1 cells, the following oligo-
nucleotides were inserted into RNAi-Ready pSIREN-RetroQ vector
(Clontech, Palo Alto, CA): 50-CCTTGTGCCTTGGATACTC-30 for mouse
C/EBPa, 50-CTGGTATCCGTTCGGAGAG-30 for mouse AIF, and 50-ACT-
ACCGTTGTTATAGGTG-30 for scrambled negative control.
2.5. Luciferase reporter assays
The human AIF promoter (593 to +1337) or mouse AIF pro-
moter (551 to +1360) was subcloned into pGL3-Basic (Promega,
Madison, WI), respectively. Luciferase assay was performed as pre-
viously described [12].
2.6. ChIP assay
U937 cells were subjected to ChIP assay as previously described
[12] using the speciﬁc anti-human C/EBPa antibody. PCR wasperformed with the following primers targeting different regions
of human AIF promoter: 50-CCACAGCAGGAGACTGTGTGTATC-30
(forward) and 50-GATCCGGCGTGTAC TTCCATC-30 (reverse) for P1,
50-CTAGAGCCAGCGTCTTTGCG-30 (forward) and 50-ACT
GCGCAGGCGTAGCACTC-30 (reverse) for P2, 50-GAATTCGGGTCT
CTTCCCAGT-30 (forward) and 50-TTGCCCCCATGAAGTAACG-30 (re-
verse) for P3, 50-GT GCTGCCCATGTTATCAAACTG-30 (forward) and
50-TGGCAGTGTCCAGGAAGCCA G-30 (reverse) for P>3000.
2.7. Retroviral infection
Retroviruses were produced as previously described [13].
2.8. Quantitative realtime-PCR
Quantitative realtime PCR was performed as previously de-
scribed [13]. Additional primers were used: 50-CAGA-
GAAGAGCCATTGCCTCC-30 (forward) and 50-ATACAATCAGGACCCT
GGCCCC-30 (reverse) for mouse AIF, 50-TTACAACAGGC-
CAGGTTTCC-30 (forward) and 50-GGCTGGCGACATACAGT ACA-30
(reverse) for mouse C/EBPa, 50-CCTTCCTTCTTGGGT ATGGA-30 (for-
ward) and 50-CTTGCTGATCCACATCTGCT-30 (reverse) for mouse b-
actin.
2.9. Western blots
Western blot was performed as described previously [13]. The
proteins were probed by antibodies against human C/EBPa (sc-
9314, Santa Cruz Biotech, Santa Cruz, CA), mouse C/EBPa (sc-61,
Santa Cruz Biotech, Santa Cruz, CA), AIF (#4642, Cell Signaling, Bev-
erly, MA), PPARc (#2443, Cell Signaling), NDUFS1, NDUFS3,
NDUFB6 and NDUFA9 (12444-1-AP, 15066-1-AP, 16037-1-AP,
20312-1-AP, Proteintech Group, Chicago, IL), NDUFA10 (ab19131,
abcam, San Francisco, CA) with mouse anti-b-actin mAb (JLA20,
Merck, Darmstadt, Germany) to conﬁrm equal loading.
2.10. Assessment of mitochondrial complex I activity
Mitochondria were isolated as previously described [14]. Com-
plex I activity was assayed according to a previous report [15] by
Fig. 2. AIF expression is positively regulated by C/EBPa. (A and B) mRNA and
proteins from U937-NC or U937-siC/EBPa cells (A) and MCF-7-EV or MCF-7-C/EBPa
cells (B) were analyzed respectively by quantitative realtime PCR and Western blot
(n = 3; ⁄⁄P < 0.005 compared to the control; Student’s t-test). (C) Total proteins
extracted from 4-week-old mouse were subjected to Western blot. The indicated
proteins were assessed.
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buffer (10 buffer containing 500 mM Tris–HCl, pH 8.1, 1% BSA,
20 lM antimycin A, 20 lM NaN3, 700 lM decylubiquinone). Final
concentration of mitochondrial protein was 20 lg/ml with DCPIP
concentration of 80 lM. The reaction was started by adding
200 lM NADH and scanned spectrophotometrically at 600 nm.
Rotenone (3 lM) was added into above system as the blank.
3. Results
3.1. AIF expression increases coincidentally with C/EBPa during 3T3-L1
adipocytic differentiation
When 3T3-L1 cells were induced to differentiate upon expo-
sure to a mixture hormonal stimuli containing 100 nM insulin,
1 lM dexamethasone and 0.5 mM 1-methyl-3-isobutyl-xanthine,
a robust upregulation of AIF expression was observed by Wes-
tern blot (Fig. 1A) and quantitative realtime PCR (Fig. 1B) ana-
lyzes. Signiﬁcant upregulation of AIF protein could be observed
from cells 4 days post-differentiation and reached maximal levels
at day 8, while AIF mRNA started to increase as early as 2 daysand began to drop after day 6. To our interest, the expression of
AIF paralleled to that of C/EBPa (Fig. 1A and B), which led us to
hypothesize that C/EBPa modulates AIF expression during 3T3-
L1 adipocyte differentiation. In order to verify this hypothesis,
3T3-L1 cells were transfected with retrovirus vector harboring
shRNA against C/EBPa (siC/EBPa) or scrambled negative control
(NC). C/EBPa was efﬁciently knocked down (Fig. 1C and D, upper
panel), and as a result, 3T3-L1 differentiation was almost com-
pletely blocked (data not shown). Intriguingly, the up-regulation
of AIF was greatly attenuated after loss of C/EBPa (Fig. 1C and D,
lower panel). Furthermore, AIF was regulated by basal levels of
C/EBPa in 0 day cells in which C/EBPa expression was extremely
low, indicating a strong regulation of C/EBPa upon AIF.
3.2. AIF is positively regulated by C/EBPa
Besides C/EBPa, a batch of transcription factors is activated
during the process of adipocyte differentiation. To reveal the
relationship between C/EBPa and AIF more directly, we em-
ployed a leukemic cell line U937, which expresses endogenous
C/EBPa under normal conditions. Knockdown of C/EBPa in
U937 cells resulted in the reduced expression of both AIF protein
and mRNA (Fig. 2A). On the contrary, when C/EBPa was ectopi-
cally expressed in breast cancer cell line MCF-7 which contains
undetectable endogenous C/EBPa, AIF expression was upregu-
lated (Fig. 2B).
To further verify the impact of C/EBPa on AIF expression, a liver-
speciﬁc C/EBPa-null mouse line was generated. C/EBPa was lost in
the liver, but not in the kidney of KO mouse. As a result, liver AIF of
KO mouse was greatly reduced while AIF in kidney remained un-
changed. Taken together, these results demonstrated that AIF
expression is regulated by C/EBPa both in vitro and in vivo.
3.3. C/EBPa activates the AIF promoter
Because C/EBPa is a transcription factor, we conducted the
following studies to determine whether C/EBPa regulates AIF at
the transcriptional level. A 2 kb DNA fragment ﬂanking human
or mouse AIF promoter was inserted into the promoterless lucif-
erase reporter plasmid pGL3-Basic, respectively. The reporter
plasmids were transfected into 293T cells. Analysis of cell lysates
36 h later revealed that both promoters were activated by
cotransfection of an expression vector encoding C/EBPa
(Fig. 3A). Furthermore, C/EBPa activates AIF promoter in a
dose-dependent manner (Fig. 3B).
C/EBPa is one of the hematopoiesis-related transcription factors
including C/EBPs, PU.1/spi-1 and runt-related transcription factor 1
(RUNX1). Overlapping of target genes between these transcription
factors is commonly seen. To ﬁnd out the situation here, AIF pro-
moter was cotransfected with C/EBPa, PU.1 and RUNX1 into
293T cells respectively. As shown in Fig. 3C, although statistically
signiﬁcant, the activation of AIF promoter by PU.1 and RUNX1
was very weak compared to that of C/EBPa. To further verify the
speciﬁcity of C/EBPa upon AIF activation, two other C/EBP family
members were also tested. C/EBPb activated AIF promoter only to
a very low extent while CHOP showed no effect (Fig. 3D).
Next, we sought to verify C/EBPa binding to the AIF gene pro-
moter by chromatin immunoprecipitation (ChIP) in U937 cells.
The precipitated DNA was subjected to PCR ampliﬁcation using
three pairs of primers, P1, P2 and P3, speciﬁc to different regions
of AIF gene promoter, as illustrated in Fig. 3E. It was astonishing
to ﬁnd that C/EBPa associated with all three regions. In addition,
P>3000, a pair of primers designed to 3 kb downstream of the tran-
scription start site was used as a negative control. Taken together,
these results clearly showed that C/EBPa binds to AIF promoter and
activates its transcription.
Fig. 3. C/EBPa activates and binds to multiple sites within AIF promoter. (A) Mouse or human AIF-luciferase reporters were cotransfected with EV or vector encoding C/EBPa
into 293T cells. Mean luciferase activity is shown relative to the cells transfected with EV. Error bars represent S.D. (n = 3; ⁄⁄P < 0.005 compared to EV; Student’s t-test). (B)
293T cells were transfected with human AIF-luciferase reporter and increasing amounts of vector encoding C/EBPa (n = 3; ⁄⁄P < 0.005; Student’s t-test). (C) Human AIF-
luciferase reporter was cotransfected with EV, vectors encoding C/EBPa, PU.1 or RUNX1 into 293T cells (n = 3; ⁄P < 0.05, ⁄⁄P < 0.005 compared to EV; Student’s t-test). (D)
Human AIF-luciferase reporter was cotransfected with EV, vectors encoding C/EBPa, C/EBPb and CHOP into 293T cells (n = 3; ⁄⁄P < 0.005 compared to EV; Student’s t-test). (E)
C/EBPa binding to AIF promoter was analyzed in U937 cells. Chromatin was immunoprecipitated with IgG or anti-C/EBPa antibody and analyzed by PCR using primers
indicated above.
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differentiation
C/EBPa is a master adipogenic transcription factor that mod-
ulates gene expression during adipocyte differentiation [8]. Thus,
we speculated that AIF upregulation by C/EBPa may play a role
in adipocyte differentiation. To address the function of AIF, we
examined the effect of inhibiting it. When 3T3-L1 cells were in-
fected with retrovirus vector harboring either NC or siAIF and
then hormonally stimulated to differentiate, Oil-Red-O staining
on day 6 after induction showed that knockdown of AIF reduced
the accumulation of lipid droplets by approximately 50% (Fig. 4A
and B). Furthermore, the expression levels of adipocyte markers
C/EBPa and PPARc were also downregulated in AIF knockdown
cells compared to those in NC cells at day 6 (Fig. 4C), indicating
that AIF participated in 3T3-L1 adipocyte differentiation.3.5. AIF knockdown compromised mitochondrial respiratory chain
complex I activity
It has been reported that mitochondria inhibition resulted in
notable suppression on adipocyte differentiation [16,17]. AIF is re-
quired for efﬁcient oxidative phosphorylation through its role in
ensuring proper assembly and functionality of mitochondrial
respiratory chain complex I [4]. In view of these, we speculated
whether AIF plays its role in adipocyte differentiation by maintain-
ing the activity of complex I. The protein levels of several complex I
subunits, including NADH dehydrogenase (ubiquinone) Fe-S pro-
tein 1 and 3 (NDUFS1 and NDUFS3), NADH dehydrogenase (ubiqui-
none) 1 beta subcomplex, 6 (NDUFB6), NADH dehydrogenase
(ubiquinone) 1 alpha subcomplex, 9 and 10 (NDUFA9 and NDU-
FA10) were detected. As expected, 3T3-L1-siAIF cells displayed
complex I deﬁciency manifested both on protein and functional
Fig. 4. AIF knockdown attenuated 3T3-L1 adipocyte differentiation. (A) On day 6 after induction of differentiation, 3T3-L-NC or 3T3-L1-siAIF cells were stained with Oil-Red-
O. (B) Quantiﬁcation of triglycerides production after Oil-Red-O staining (n = 3; ⁄⁄P < 0.005 compared to the control; Student’s t-test). (C) Total protein was collected and
subjected to Western blot with indicated antibodies.
Fig. 5. AIF knockdown attenuated mitochondrial respiratory chain complex I
activity. (A) Western blot determination of the subunit composition of complex I in
3T3-L1-NC or 3T3-L1-siAIF cells using indicated antibodies. (B) Mitochondrion-
enriched fractions from 3T3-L1-NC or 3T3-L1-siAIF cells were monitored for the
complex I activity (n = 3; ⁄⁄P < 0.005 compared to the control; Student’s t-test).
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isolated mitochondria (Fig. 5B). These results suggest that AIF par-
ticipates in adipocyte differentiation, probably through maintain-
ing mitochondrial function.
4. Discussion
In this study we showed for the ﬁrst time that AIF is robustly
upregulated during 3T3-L1 adipocyte differentiation, for which C/
EBPa is responsible. Next, we identiﬁed C/EBPa as a transcription
factor for AIF gene. C/EBPa activates AIF promoter through associ-
ation with multiple sites. Multiple-site binding is possibly a com-
mon mechanism for C/EBPa as a strategy for strong activation.
For example, C/EBPa binds to seven sites in the human AFP gene
promoter and enhancer regions [18].
C/EBPa is a master regulator for adipocyte differentiation. We
found that the ability of C/EBPa to induce adipocyte differentiation
is partially mediated by AIF, as knockdown of AIF could attenuate
3T3-L1 differentiation to adipocytes. It is one of the few cellular
activities that AIF was found to be involved irrespective of its
well-deﬁned apoptosis-induction role. One possible reason as we
speculated is the decreased stability of mitochondrial complex I
and the consequently impaired mitochondrial functionality caused
by AIF loss. As reported, mitochondria underwent massive prolifer-
ation during adipocytes differentiation process [16,17]. Treatments
with mitochondrial respiratory chain inhibitors resulted in notable
suppression on adipocyte differentiation [17]. As a result of the
accelerated mitochondrial biogenesis, the cellular abundance of
complex I increased splendidly [16]. In order to maintain the high
levels of complex I, more molecules that help with assembly are
needed, which led us to infer that AIF expression is elevated partly
to meet the demand of complex I stabilization.
In this work, we demonstrated that AIF is a target gene of C/
EBPa and participates in C/EBPamediated 3T3-L1 adipocyte differ-
entiation. Considering the fact that the known functions of C/EBPa
2312 S.-M. Shen et al. / FEBS Letters 585 (2011) 2307–2312and AIF are poorly related, in the future, it is of great interest for us
to explore whether AIF is involve in other cellular activities driven
by C/EBPa or whether AIF endows C/EBPa with new functions.
Acknowledgements
This work was supported in part by the Ministry of Science and
Technology of China (Grant No. 2009CB918404), the National Nat-
ural Science Foundation of China (Grant Nos. 30630034, 90813034,
81071668, 30971276 and 30971488), the Shanghai Science and
Technology Commission (Grant Nos. 08JC1413700,
11QH1401700) and the Shanghai Municipal Education
Commission.
References
[1] Susin, S.A. et al. (1999) Molecular characterization of mitochondrial apoptosis-
inducing factor. Nature 397, 441–446.
[2] Susin, S.A. et al. (2000) Two distinct pathways leading to nuclear apoptosis. J.
Exp. Med. 192, 571–580.
[3] Punj, V. and Chakrabarty, A.M. (2003) Redox proteins in mammalian cell
death: an evolutionarily conserved function in mitochondria and prokaryotes.
Cell. Microbiol. 5, 225–231.
[4] Vahsen, N. et al. (2004) AIF deﬁciency compromises oxidative
phosphorylation. EMBO J. 23, 4679–4689.
[5] Brown, D. et al. (2006) Loss of AIF function causes cell death in the mouse
embryo, but the temporal progression of patterning is normal. Proc. Natl. Acad.
Sci. USA 103, 9918–9923.
[6] Pospisilik, J.A. et al. (2007) Targeted deletion of AIF decreases mitochondrial
oxidative phosphorylation and protects from obesity and diabetes. Cell 131,
476–491.
[7] Ghezzi, D. et al. (2010) Severe X-linked mitochondrial encephalomyopathy
associated with a mutation in apoptosis-inducing factor. Am. J. Hum. Genet.
86, 639–649.[8] Lin, F.T. and Lane, M.D. (1992) Antisense CCAAT/enhancer-binding protein
RNA suppresses coordinate gene expression and triglyceride accumulation
during differentiation of 3T3-L1 preadipocytes. Genes Dev. 6, 533–544.
[9] Zhang, D.E., Zhang, P., Wang, N.D., Hetherington, C.J., Darlington, G.J. and
Tenen, D.G. (1997) Absence of granulocyte colony-stimulating factor signaling
and neutrophil development in CCAAT enhancer binding protein alpha-
deﬁcient mice. Proc. Natl. Acad. Sci. USA 94, 569–574.
[10] Flodby, P., Barlow, C., Kylefjord, H., Ahrlund-Richter, L. and Xanthopoulos, K.G.
(1996) Increased hepatic cell proliferation and lung abnormalities in mice
deﬁcient in CCAAT/enhancer binding protein alpha. J. Biol. Chem. 271, 24753–
24760.
[11] Song, L.P. et al. (2008) Hypoxia-inducible factor-1alpha-induced
differentiation of myeloid leukemic cells is its transcriptional activity
independent. Oncogene 27, 519–527.
[12] Gu, Z.M. et al. (2010) Pharicin B stabilizes retinoic acid receptor-alpha and
presents synergistic differentiation induction with ATRA in myeloid leukemic
cells. Blood 116, 5289–5297.
[13] Shen, S.M., Yu, Y., Wu, Y.L., Cheng, J.K., Wang, L.S. and Chen, G.Q. (2010)
Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-
3 activation and apoptosis induction in myeloid leukemic cells. Carcinogenesis
31, 419–426.
[14] Yu, Y., Wang, L.S., Shen, S.M., Xia, L., Zhang, L., Zhu, Y.S. and Chen, G.Q. (2007)
Subcellular proteome analysis of camptothecin analogue NSC606985-treated
acute myeloid leukemic cells. J. Proteome Res. 6, 3808–3818.
[15] Long, J., Wang, X., Gao, H., Liu, Z., Liu, C., Miao, M. and Liu, J. (2006)
Malonaldehyde acts as a mitochondrial toxin: Inhibitory effects on respiratory
function and enzyme activities in isolated rat liver mitochondria. Life Sci. 79,
1466–1472.
[16] Wilson-Fritch, L., Burkart, A., Bell, G., Mendelson, K., Leszyk, J., Nicoloro, S.,
Czech, M. and Corvera, S. (2003) Mitochondrial biogenesis and remodeling
during adipogenesis and in response to the insulin sensitizer rosiglitazone.
Mol. Cell. Biol. 23, 1085–1094.
[17] Lu, R.H., Ji, H., Chang, Z.G., Su, S.S. and Yang, G.S. (2010) Mitochondrial
development and the inﬂuence of its dysfunction during rat adipocyte
differentiation. Mol. Biol. Rep. 37, 2173–2182.
[18] Li, H.M., Ikeda, H., Nakabayashi, H., Nishi, S. and Sakai, M. (2007) Identiﬁcation
of CCAAT enhancer binding protein alpha binding sites on the human alpha-
fetoprotein gene. Gene 389, 128–135.
